Loomis Sayles Strategic Alpha Fund BMRN Holdings History
Loomis Sayles Strategic Alpha Fund's BioMarin Pharmaceutical Inc Holding Summary
As of 2025-03-31, Natixis Funds Trust II held 20,331.00 shares of BioMarin Pharmaceutical Inc(BMRN), totaling $1.44 Mil. This investment constitutes 12.95% of their stock portfolio, and Natixis Funds Trust II now holds 0.01% of the outstanding BioMarin Pharmaceutical Inc(BMRN) stock.
The initial trade took place in 2024Q2. And since then Loomis Sayles Strategic Alpha Fund has made 3 purchases of BMRN, at an average price of $76.37, for a total of 20,331.00 shares. Based on historical transaction data and BMRN's current price of $59.20, Loomis Sayles Strategic Alpha Fund's estimated gain on his BMRN holdings is $-349,126.37, reflecting a -22.48% gain to date.
Loomis Sayles Strategic Alpha Fund BMRN ($59.20) Holding Chart
Loomis Sayles Strategic Alpha Fund BMRN ($59.20) Quarterly Buys and Sells
| Period | Bought/Sold (Sh.) | % Change | Qtr. End Shares | Avrg. Price |
|---|---|---|---|---|
| Shares Bought | 0 | Average Price $-/Share | ||
| Shares Sold | 0 | Average Price $-/Share | ||
| Current Price $0.00 | Total Estimated Gain 0 % | |||
Top Ranked Articles
- 1
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
